Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Pharvaris N.V. | 137,500 | reported | 18 May 2026 | tx 2−4,584 |
| Axovant Sciences Ltd. | 42,000 | reported | 15 Apr 2021 | tx 8+541,414−77,914 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | SALE | Pharvaris N.V. | 2,292 | 29.22 USD | 10b5-1 |
| 16 Apr 2026 | SALE | Pharvaris N.V. | 2,292 | 28.60 USD | |
| 15 Apr 2021 | GRANT_AWARD | Axovant Sciences Ltd. | 42,000 | 0.00 USD | deriv |
| 15 Apr 2020 | GRANT_AWARD | Axovant Sciences Ltd. | 17,500 | 0.00 USD | deriv |
| 15 Apr 2019 | GRANT_AWARD | Axovant Sciences Ltd. | 255,000 | 0.00 USD | deriv |
| 15 Mar 2018 | GRANT_AWARD | Axovant Sciences Ltd. | 75,000 | 0.00 USD | deriv |
| 29 Dec 2017 | EXERCISE | Axovant Sciences Ltd. | 77,914 | 0.90 USD | |
| 29 Dec 2017 | EXERCISE | Axovant Sciences Ltd. | 77,914 | 0.00 USD | deriv |
| 28 Apr 2017 | GRANT_AWARD | Axovant Sciences Ltd. | 27,000 | 0.00 USD | deriv |
| 29 Apr 2016 | GRANT_AWARD | Axovant Sciences Ltd. | 47,000 | 0.00 USD | deriv |